Role of Embolization of Thyroid Arteries as a Treatment for Different Thyroid Disorders
- Sponsor
- Assiut University
- Study ID
- NCT06537141
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Goiter Diffuse
- Goiter Malignant
- Goiter, Nodular
- Graves Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- selective embolization of thyroid arteries (SETA) — PROCEDUREselective embolization of thyroid arteries
Study Details
To investigate the safety and efficacy of selective embolization of thyroid arteries (SETA) as adjunctive or definitive treatment in different thyroid disorders
Key Dates
- Start date
- Aug 10, 2024
- Status verified
- Aug 2024
- Primary completion
- Jul 9, 2026
- Completion
- Jul 30, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Active Comparator: graves disease patients
- Active Comparator: multinodular goiter
Primary Outcome Measure
To investigate the safety of selective embolization of thyroid arteries (SETA) as adjunctive or definitive treatment in different thyroid disorders [ Time Frame: Up to 12 months follow up after embolization ]
Related Studies
- Personalized Treatment in Thyroid DisordersRecruiting · Johns Hopkins University · Baltimore, Maryland
- Preoperative Corticosteroids in Autoimmune Thyroid DiseasePHASE4 · Recruiting · Indiana University · Indianapolis, Indiana
- The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid DysfunctionRecruiting · Walter Reed National Military Medical Center · Bethesda, Maryland
- Study of BHV-1300 in Graves' DiseasePHASE1 · Recruiting · Biohaven Therapeutics Ltd. · South Gate, California